PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
Not yet recruiting · NCT07649421 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07649421 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| West China Hospital | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital, Sichuan University | Chengdu | China | 129 |